Iridium-192 is one radioisotope used in brachytherapy, in which a radioactive so
ID: 867822 • Letter: I
Question
Iridium-192 is one radioisotope used in brachytherapy, in which a radioactive source is placed inside a patient's body to treat cancer. Brachytherapy allows the use of a higher than normal dose to be placed near the tumor while lowering the risk of damage to healthy tissue. Iridium-192 is often used in the head or breast. Answer the following three questions (a, b, and c) based on the radioactive decay curve of iridium-192, shown below. Click on the graph and move the mouse over a point to get values for that point.
at 105 days the sample remaining (%) is 37.31%
a) If the initial sample is 1.75 g, what mass of the original iridium-192 remains after 105 days?
Explanation / Answer
As the text says, there is 37.31% left at 105 days later
If we use 1.75 g as 100% then
1.75 * 0.3731 = 0.6529 g are left
mass = 0.6529 g
Related Questions
drjack9650@gmail.com
Navigate
Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.